Jump to content
  • Sign Up
Celiac.com Sponsor:

Celiac.com Sponsor:

Scott Adams

Biolinerx Obtains Regulatory Approval To Initiate Bl-7010 Phase 1/2 Trial For ... - News-Medical.net

Rate this topic

Recommended Posts

BioLineRx obtains regulatory approval to initiate BL-7010 Phase 1/2 trial for ...


The Phase 1/2 study is a two-part (single and repeated), double-blind, placebo-controlled, dose escalation study of BL-7010 in up to 32 patients at a world-leading site for celiac disease research in Finland. The primary objective of the study is to ...

BioLineRx (BLRX) Receives Approval in Finland to Commence BL-7010 Phase ... StreetInsider.com (subscription)

all 6 news articles »

View the full article

Share this post

Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...